Compounds > gliclazide

gliclazide and cholic acid

gliclazide has been researched along with cholic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Al-Salami, H; Chen-Tan, N; Golocorbin-Kon, S; Lalic-Popovic, M; Martinez, J; Mathavan, S; Mikov, M; Mooranian, A; Mukkur, TK; Negrulj, R; Sciarretta, J; Stojancevic, M1
Al-Salami, H; Calasan, J; Golocorbin-Kon, S; Lalic-Popovic, M; Mikov, M; Milijasevic, B; Vukmirovic, S1

Other Studies

3 other study(ies) available for gliclazide and cholic acid

ArticleYear
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations.
    Pharmaceutical development and technology, 2015, Volume: 20, Issue:6

    Topics: Administration, Oral; Alginates; Animals; Capsules; Cholic Acid; Diabetes Mellitus, Type 1; Drug Carriers; Drug Compounding; Excipients; Gliclazide; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Rats

2015
High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect.
    European journal of drug metabolism and pharmacokinetics, 2017, Volume: 42, Issue:6

    Topics: Animals; Bile Acids and Salts; Blood Glucose; Cholic Acid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Compounding; Drug Interactions; Gliclazide; Hypoglycemic Agents; Male; Rats

2017